Search company, investor...

Kurobe Pharmaceuticals

Total Raised

$5M

Investors Count

2

Deal Terms

1

Funding, Valuation & Revenue

1 Fundings

Kurobe Pharmaceuticals has raised $5M over 1 rounds.

Kurobe Pharmaceuticals's latest funding round was a Series A for $5M on June 4, 2013.

Kurobe Pharmaceuticals's latest post-money valuation is from June 2013.

Sign up for a free demo to see Kurobe Pharmaceuticals's valuations in June 2013 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/4/2013

Series A

$5M

$99M

0

FY undefined

1

Date

6/4/2013

Round

Series A

Amount

$5M

Investors

Valuation

$99M

Revenue

0

FY undefined

Sources

1

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Kurobe Pharmaceuticals Deal Terms

1 Deal Term

Kurobe Pharmaceuticals's deal structure is available for 1 funding round, including their Series A from June 04, 2013.

Round

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$99M

$99M

$99M

$99M

Kurobe Pharmaceuticals Investors

2 Investors

Kurobe Pharmaceuticals has 2 investors. Tullis Health Investors invested in Kurobe Pharmaceuticals's Series A funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/4/2013

6/4/2013

1
Series A

Private Equity

Connecticut

00/00/0000

00/00/0000

Private Medical Equity

Subscribe to see more

Angel Investor (Group)

United States

First funding

6/4/2013

00/00/0000

Last Funding

6/4/2013

00/00/0000

Investor

Private Medical Equity

Rounds

1
Series A

Subscribe to see more

Board Seats

Type

Private Equity

Angel Investor (Group)

Location

Connecticut

United States

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.